This synuclein family member, also known as breast cancer‐specific gene (BCSG1),[70] Synoretin,[71] and Persyn,[72] has been predominantly associated with various forms of cancer, as a predictive and diagnostic value, as a marker for assessing tumor grade, and as a potential therapeutic target.[73] High levels of SNCG gene expression have been also reported in adipose tissue, namely in mature adipocytes. This evidence concerns the gene SNCG and neoplasm.